Medical Advisory Board

The 22 medical advisors we rely upon to guide and review our work are leading authorities on bone marrow failure disease in the U.S. and overseas. Thanks to their excellent oversight, we can be confident that everything we teach and publish represents the latest thinking, research and best practices in the fields of hemotology and oncology.

Position About

Richard Stone, MD
Dana-Farber Cancer Center


Mikkael Sekeres, MD, MS
Cleveland Clinic Taussig Cancer Center

Members Pamela Becker, MD, PhD
University of Washington School of Medicine

Carlos M. de Castro, III, MD
Duke University Medical Center

  H. Joachim Deeg, MD
Fred Hutchinson Cancer Research Center

Amy E. DeZern, MD, MHS
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins


Benjamin L. Ebert, MD, PhD
Dana-Farber/Harvard Cancer Center


Guillermo Garcia-Manero, MD
MD Anderson Cancer Center


Aristoteles Giagounidis, MD, PhD
Marienhospital - Dusseldorf, Germany


Steven D. Gore, MD
Yale School of Medicine


Timothy Graubert, MD
Massachusetts General Hospital Cancer Center


Alan List, MD
H. Lee Moffitt Cancer Center & Research Institute

  Jaroslaw P. Maciejewski, MD, PhD
Cleveland Clinic Taussig Cancer Center

David Margolis, MD
Medical College of Wisconsin


Judith Marsh, MD
Kings College Hospital - London, UK


Stephen D. Nimer, MD
Sylvester Comprehensive Cancer Center, University of Miami


Olatoyosi Odenike, MD
University of Chicago

  Ronald Paquette, MD
UCLA Medical Center

Gail J. Roboz, MD
Weill Medical College of Cornell University

  Valeria Santini, M.D.
University of Florence, Florence, Italy

B. Douglas Smith, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins


Neal Young, MD
National Institutes of Health